Skip to main content

Moderna testing potential monkeypox vaccines

Share

Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.

The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads.

Moderna did not immediately respond to a request for more details on the monkeypox vaccines.

The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S BAVA.CO, for use in monkeypox cases.

Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta

CTVNews.ca Top Stories

opinion

opinion How to use your credit card as a powerful wealth-building tool

Irresponsibly using a credit card can land you in financial trouble, but personal finance columnist Christopher Liew says when used properly, it can be a powerful wealth-building tool that can help grow your credit profile and create new opportunities.

Local Spotlight